Cargando…

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation

BACKGROUND: The risk of ventricular arrhythmias in patients on QT prolonging drugs is indicated to be increased early after cardioversion (CV) of atrial fibrillation (AF) to sinus rhythm (SR). Sotalol, used to prevent AF relapse, prolongs cardiac repolarization and corrected QT interval (QTc). A pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenhoff, Hanna, Darpö, Börje, Page, Alex, Couderc, Jean Philippe, Tornvall, Per, Frick, Mats
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293609/ https://www.ncbi.nlm.nih.gov/pubmed/33629473 http://dx.doi.org/10.1111/anec.12834

Ejemplares similares

Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol
por: Lenhoff, H, et al.
Publicado: (2023)

Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation
por: Decloedt, Annelies, et al.
Publicado: (2018)

QT prolongation-related ventricular arrhythmia associated with atrial fibrillation electrical cardioversion
por: Rav Acha, M, et al.
Publicado: (2023)

Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation
por: Varela, Daniel L., et al.
Publicado: (2022)

Recent-onset atrial fibrillation: a study exploring the elements of Virchow’s triad after cardioversion
por: Arvanitis, Panagiotis, et al.
Publicado: (2021)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
por: Wharton, John Marcus, et al.
Publicado: (2022)

Intravenous sotalol for conversion of atrial flutter in infants
por: Aljohani, Othman A., et al.
Publicado: (2018)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Publicado: (2022)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Omadacycline on QT/QTc Intervals in Healthy Subjects
por: Darpo, Borje, et al.
Publicado: (2019)

Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardiac Implantable Electronic Devices for Therapy Monitoring
por: Mascarenhas, Daniel A. N., et al.
Publicado: (2021)

Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta‐analysis
por: Singh, Jagmeet P., et al.
Publicado: (2023)

Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study
por: Borin, Marie T., et al.
Publicado: (2019)

Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals
por: Darpo, Borje, et al.
Publicado: (2017)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
por: Rochlani, Yogita M., et al.
Publicado: (2016)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
por: Höglund, Niklas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v96t970amquvbrk09p89v8vsj5